EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic-Category Medication Burden Among Adults With Treated Diabetes in the Health Survey for England 2022

Therapeutic-Category Medication Burden bei Erwachsenen mit behandeltem Diabetes in der Health Survey for England 2022

Duaa Abdullah Bafail, Yusuff Adebayo Adebisi

SN Comprehensive Clinical Medicine · 05.10.2026 · 8 (1)

DOI: 10.1007/s42399-026-02755-4 ↗

Auf einen Blick

In einer Querschnittsanalyse der HSE 2022 erfüllten 40,8 % der Erwachsenen mit behandeltem Diabetes die Schwelle von ≥ 3 therapeutischen Kategorien. Höhere Werte zeigten sich in einigen Alters- und Deprivationsgruppen.

Fragestellung

Wie ist die therapeutische Kategorienlast bei Erwachsenen mit behandeltem Diabetes in der HSE 2022 verteilt, und welche soziodemografischen Muster bestehen?

Methode

Querschnittsdaten der HSE 2022; Erwachsene ≥ 16 Jahre mit Diabetes und antidiabetischer Behandlung nach Nurse-Visit; ungewichtete Analysen, logistische Regression zu Alter, Geschlecht und Deprivation.

Ergebnisse

N = 262; 107/262 (40,8 %; 95 %-KI 34,8–47,1) erfüllten ≥ 3 Kategorien. Alter 55–64 vs. < 55: aOR 3,07 (95 %-KI 1,12–8,46); stärkste Deprivation vs. geringste: aOR 3,21 (95 %-KI 1,38–7,47).

Einschränkungen

Ungewichtete Analysen beschreiben die ausgewählte Stichprobe, nicht die Prävalenz in der Bevölkerung. Schätzungen zu Behandlungsgruppen waren unpräzise, besonders bei Insulin-only-Nutzern.

Schlussfolgerung der Autor:innen

In dieser HSE-Nurse-Visit-Stichprobe erfüllten etwa zwei von fünf Teilnehmenden die Studie-spezifische Schwelle von ≥ 3 Kategorien. Es zeigten sich höhere Werte in einigen Alters- und Deprivationsgruppen.

Kernaussagen

  • 40,8 % erfüllten die Schwelle von ≥ 3 Kategorien
  • Höhere Odds bei 55–64 Jahren und in der stärksten Deprivation
  • Keine klaren Unterschiede nach Diabetes-Behandlungsmodalität

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift SN Comprehensive Clinical Medicine, online erschienen am 05.10.2026. Verfasst von Duaa Abdullah Bafail und 1 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polypharmacy is commonly defined using counts of individual medicines, but definitions vary and category-based measures capture a different construct. We described therapeutic-category medication burden and associated sociodemographic patterns among adults with treated diabetes in the Health Survey for England (HSE) 2022 nurse-visit analytical sample.

Methods

Cross-sectional HSE 2022 data included adults (≥ 16 years) who completed the nurse visit, reported diabetes, and received antidiabetic treatment ( N = 262). Medication burden was the number of six broad therapeutic categories with ≥ 1 prescribed medicine taken in the past 7 days; the primary outcome was ≥ 3 categories. Analyses were unweighted and describe the selected analytical sample rather than population-level prevalence. Logistic regression examined age, sex and area deprivation; treatment-modality analyses included 256 participants with classifiable treatment status. Sensitivity analyses examined stricter thresholds of ≥ 4 and ≥ 5 categories and alternative outcome definitions excluding antibacterial medications and excluding both antibacterial medications and NSAIDs.

Results

Overall, 107/262 participants (40.8%; exact 95% CI 34.8–47.1) met the ≥ 3-category threshold. The 55–64-year group had higher adjusted odds than the < 55 group (aOR 3.07, 95% CI 1.12–8.46), and the most deprived quintile had higher odds than the least deprived quintile (aOR 3.21, 95% CI 1.38–7.47); however, overall Wald tests for age ( p = 0.128) and deprivation ( p = 0.089) were not statistically significant. No statistically significant differences were detected across treatment groups (overall Wald p = 0.824), and estimates were imprecise, particularly for insulin-only users. Using stricter thresholds, 11.1% (29/262; 95% CI 7.5–15.5) met the ≥ 4-category threshold and 3.4% (9/262; 95% CI 1.6–6.4) met the ≥ 5-category threshold. Excluding antibacterial medications had little effect on the ≥ 3-category proportion (40.5%), whereas excluding both antibacterial medications and NSAIDs reduced it to 35.9%.

Conclusions

In this HSE nurse-visit analytical sample, about two in five participants met the study-specific ≥ 3-category medication-burden threshold. Higher burden was observed in some age and deprivation groups, while no clear differences were detected across diabetes treatment modalities. The findings highlight the breadth of therapeutic-category exposure among adults with treated diabetes and the potential value of comprehensive medication review that considers both clinical and socioeconomic context.

Zitieren

APA

Bafail, D. A., & Adebisi, Y. A. (2026). Therapeutic-Category Medication Burden Among Adults With Treated Diabetes in the Health Survey for England 2022. SN Comprehensive Clinical Medicine, 8(1). https://doi.org/10.1007/s42399-026-02755-4

Vancouver

Bafail DA, Adebisi YA. Therapeutic-Category Medication Burden Among Adults With Treated Diabetes in the Health Survey for England 2022. SN Comprehensive Clinical Medicine. 2026;8(1). doi:10.1007/s42399-026-02755-4

BibTeX
@article{Bafail2026,
  author = {Bafail, Duaa Abdullah and Adebisi, Yusuff Adebayo},
  title = {Therapeutic-Category Medication Burden Among Adults With Treated Diabetes in the Health Survey for England 2022},
  journal = {SN Comprehensive Clinical Medicine},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1007/s42399-026-02755-4}
}
Kostenlos starten →